Skip to Content

GP 122 (Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg)

Pill with imprint GP 122 is Yellow, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GP 122

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg GP 122

Hydrochlorothiazide and Lisinopril

Imprint
GP 122
Strength
12.5 mg / 20 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin converting enzyme inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-1176

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.